Mersana Therapeutics Inc
F:0M4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mersana Therapeutics Inc
F:0M4
|
US |
|
Wipro Ltd
NYSE:WIT
|
IN |
|
C
|
China Resources Beer Holdings Co Ltd
XMUN:CHK
|
HK |
|
Betsson AB
OTC:BTSNY
|
SE |
|
F
|
Franchetti SpA
MIL:FCH
|
IT |
|
V
|
Vext Science Inc
XMUN:VV5
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0M4's stock price target?
Not Available
0M4 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Mersana Therapeutics Inc?
Projected CAGR
11%
Over the last 8 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 11%.